share_log

德琪醫藥-B:自願公告 ATG-010(塞利尼索)用於治療復發性及╱ 或難治性多發性骨髓瘤及彌漫性大B細胞淋巴瘤取得台灣新藥上市申請批准

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT NDA APPROVAL IN TAIWAN FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA AND DIFFUSE LARGE B-CELL LYMPHOMA

Oct 21, 2022 07:52
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more